Hiroshi Takagi
No ORCID on file
· 14 papers in corpus
· active 1988-2015
Study types
- article 12
- book-chapter 1
- other 1
Condition tags
- endometriosis 11
- adenomyosis 4
- dysmenorrhea 1
- thoracic_endometriosis 1
- bladder_endometriosis 1
Top journals
- Clinical and experimental obstetrics & gynecology 2
- European journal of obstetrics, gynecology, and reproductive biology 2
- Archives of gynecology and obstetrics 1
- Fertility and Sterility 1
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1
Frequent coauthors
- Atsushi Imai 12
- Kazutoshi Matsunami 10
- Satoshi Ichigo 10
- Takagi H 8
- Imai A 7
- Matsunami K 5
- Ichigo S 5
- Atsushi Takagi 2
- Horibe S 2
- Shinji Horibe 2
article
Thoracic endometriosis is characterized by the presence of endometrial-like glands...
article
2015
BACKGROUND: Estrogen deprivation therapy for myoma/adenomyosis decreases bone mineral density and can only be applied in the short term, as temporizing measures in the premenopausal woman. OBJECTIVE: To examine the effects of bisphosphonate…
article
2015
Gastrointestinal (GI) perforation accounts for over 90% of acute abdomen and pneumoperitoneum. The presence of pneumoperitoneum secondary to spontaneously perforated pyometra is an interesting yet confusing finding given the absence of gast…
article
2014
Background: Ovarian remnant syndrome is a rare gynecologic complication, most induced by difficult bilateral salpingo-oophorectomy (BSO) with the residual ovarian tissue on the pelvic wall. The residual ovarian tissue may eventually cause m…
article
2014
Intrauterine devices (IUDs) provide highly effective, long-term, safe, reversible contraception, and are the most widely used reversible contraceptive method worldwide. The levonorgestrel-releasing IUD (LNG-IUD), originally designed for lon…
article
2014
Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review)
Ovarian remnant syndrome (ORS) is a rare, but well-known gynecological complication, most often induced by difficult bilateral salpingo-oophorectomy (BSO) procedures that leave residual ovarian tissue on the pelvic wall. The most common pre…
article
2012
Pelvic tumors with normal-appearing shapes of ovaries and uterus presenting as an emergency (Review)
Abdominal pain with an associated pelvic mass is a common problem in everyday practice. Concerns about ectopic pregnancy, torsion of an enlarged ovary or malignancy usually dominate the diagnostic evaluation. On physical and imaging examina…
book-chapter
2012
Sequential Management with Gonadotropin-Releasing Hormone Agonist and Dienogest of Endometriosis-Associated Uterine Myoma and Adenomyosis
other
2011
PURPOSE: Uterine leiomyomas are the most common benign tumors of reproductive age women, but there is no effective medical therapy to data. Aim of this study was to examine and compare the efficacy of gonadotropin-releasing hormone agonist …
article
2011
Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report.
BACKGROUND: Because of its low incidence, medical treatment of has not yet been well established although surgical excision is generally considered effective. We report the first case of primary bladder endometriosis successfully managed wi…
article
1999
ObjectiveTo explore endometriosis-related molecules in patients with use of differential display analysis.DesignProspective study.SettingNagoya City University Medical School, Nagoya, Japan.Patient(s)Women with endometriosis (n = 27) and wi…
article
1998
Changes in serum glucose levels were examined in a female with insulin-independent diabetes who received a gonadotropin-releasing hormone (GnRH) analog treatment for pelvic endometriosis. The mean blood glucose levels were higher on buserel…
article
1998
Levels of CA125, CA72-4 and CA19-9, serum markers for ovarian cancer, were measured throughout menstrual cycles in a patient with probable pelvic endometriosis. The patient had CA125 levels >1000 U ml(-1), CA72-4>10 U ml(-1) and CA19-9>150 …
article
1988